Skip to main content

Table 2 HE4 concentrations in serum, peritoneal fluid and tumor/cyst fluid and CA125 concentrations in serum in examined groups

From: HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

  HE4-peritoneal fluid [pmol/L] HE4- serum [pmol/L] CA125- serum [mIU/ml] HE4 –tumor/cyst fluid [pmol/L]
Group I 3322 452.05 885.45 9162
[median/95% CI] [10.78-6633.22] [-272.37-1176.47] [-732.04-2502.94] [9157.69-9166.3]
Group II 2150 53.25 33.250 2694
[median/95% CI] [-1334.88-5634.88] [28.46-78.04] [-8.01-74.51] [-1902.9-7290.9]
p value 0.206376 0.0000001 0.0000001 -
Group I 3322 452.05 885.45 9162
[median/95% CI] [10.78-6633.22] [-272-1176.47] [-732.04-2502.94] [9157.69-9166.3]
Group III 627.4 87.6 231.6 10522
[median/95% CI] [-132.1-1386.9] [17.63-157.57] [-191.76-654.96] -
p value 0.05929 0.001652 0.010584 -
Group II 2150 53.25 33.250 2694
[median/95% CI] [-1334.88-5634.88] [28.46-78.04] [-8.01-74.51] [-1902.9-7290.9]
Group III 627.4 87.6 231.6 10522
[median/95% CI] [-132.1-1386.9] [17.63-157.57] [-191.76-654.96] -
p value 0.0797 0.003943 0.043166 -